SCHEMBL6852822

SCHEMBL6852822

CC(O)CC1C=CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143894 0.98 KDM4E (0.31) —
SCHEMBL7143031 0.98 KDM4E (0.31) —
SCHEMBL7143029 0.98 KDM4E (0.31) —
SCHEMBL13767336 0.94 PSMB11 (0.30) —
SCHEMBL12657295 0.94 PSMB11 (0.30) —
SCHEMBL14287526 0.86 — —
SCHEMBL7994792 0.84 NPC1 (0.30) —
SCHEMBL28637089 0.78 KDM4E (0.33) —
SCHEMBL1524643 0.78 — —
SCHEMBL1698014 0.73 USP2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448566-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2004-08-25 — — EP disclosed
WO-2003045942-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-06-05 — — WO disclosed
Send feedback